99 related articles for article (PubMed ID: 8229245)
1. Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
Inoue Y; Momose T; Machida K; Honda N; Tsutsumi K
J Nucl Med; 1993 Nov; 34(11):1984-6. PubMed ID: 8229245
[TBL] [Abstract][Full Text] [Related]
2. An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin.
Inoue Y; Momose T; Machida K; Honda N; Mamiya T; Takahashi T; Tsutsumi K
Clin Nucl Med; 1995 Apr; 20(4):340-5. PubMed ID: 7788992
[TBL] [Abstract][Full Text] [Related]
3. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases.
Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
Radiat Med; 1994; 12(5):225-9. PubMed ID: 7863027
[TBL] [Abstract][Full Text] [Related]
4. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.
Touho H; Karasawa J; Ohnishi H
Stroke; 1996 Feb; 27(2):282-9. PubMed ID: 8571424
[TBL] [Abstract][Full Text] [Related]
5. A new method for monitoring the cerebrovascular response to acetazolamide using 99mTc-DTPA-HSA.
Inoue Y; Momose T; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Kashimada A
Radiat Med; 1992; 10(2):45-7. PubMed ID: 1626056
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the cerebrovascular response to acetazolamide using 99mTc-DTPA-HSA: methodological considerations.
Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
Radiat Med; 1994; 12(4):189-92. PubMed ID: 7809415
[TBL] [Abstract][Full Text] [Related]
7. Delayed imaging of Tc-99m-DTPA-HSA SPECT in subacute cerebral infarction.
Inoue Y; Momose T; Machida K; Honda N; Mamiya T; Takahashi T; Sasaki Y
Radiat Med; 1993; 11(5):214-6. PubMed ID: 8290699
[TBL] [Abstract][Full Text] [Related]
8. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
[TBL] [Abstract][Full Text] [Related]
9. SPECT and MRI evaluations of the posterior circulation in moyamoya disease.
Yamada I; Murata Y; Umehara I; Suzuki S; Matsushima Y
J Nucl Med; 1996 Oct; 37(10):1613-7. PubMed ID: 8862293
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of cerebral blood volume by 99mTc-DTPA-HSA SPECT.
Inoue Y; Momose T; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Kinoshita M; Tsutsumi K; Asano T
Radiat Med; 1992; 10(5):184-8. PubMed ID: 1438926
[TBL] [Abstract][Full Text] [Related]
11. Substraction acetazolamide SPECT co-registered to MRI in moyamoya disease: quantitative cerebrovascular reserve map.
Cortés J; Arias-Rivas S; Rodriguez-Yañez M; Blanco M; Aguiar P
Clin Nucl Med; 2014 Apr; 39(4):399-401. PubMed ID: 23510893
[TBL] [Abstract][Full Text] [Related]
12. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.
Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Nagamachi S; Kodama T; Watanabe K; Ueda T; Wakisaka S
J Nucl Med; 1994 Jan; 35(1):44-50. PubMed ID: 8271059
[TBL] [Abstract][Full Text] [Related]
13. Hyperventilation technetium-99m-HMPAO brain SPECT in moyamoya disease to assess risk of natural childbirth.
Kume N; Hayashida K; Shimotsu Y; Matsunaga N
J Nucl Med; 1997 Dec; 38(12):1894-7. PubMed ID: 9430464
[TBL] [Abstract][Full Text] [Related]
14. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.
Devous MD; Payne JK; Lowe JL
J Nucl Med; 1992 Nov; 33(11):1919-24. PubMed ID: 1432149
[TBL] [Abstract][Full Text] [Related]
15. Lymphoscintigraphy using technetium-99m HSA-DTPA with SPECT/CT in chylothorax after childbirth.
Momose M; Kawakami S; Koizumi T; Yoshida K; Kanda S; Kondo R; Kadoya M
Radiat Med; 2008 Oct; 26(8):508-11. PubMed ID: 18975054
[TBL] [Abstract][Full Text] [Related]
16. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; measurement of cerebral blood volume (CBV) with 99mTc-RBC SPECT].
Kuroda S; Takigawa S; Kamiyama H; Abe H; Sakuragi M; Motomiya M; Nakagawa T; Mitsumori K; Tsuru M
No Shinkei Geka; 1990 Mar; 18(3):259-66. PubMed ID: 2359476
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m DTPA-HSA SPECT in a case of hemangioma of the spleen.
Ohta H; Tsuchisaki M; Mihara Y; Takeda H; Taniguchi T; Konibuchi T
Clin Nucl Med; 1995 Jul; 20(7):636. PubMed ID: 7554671
[No Abstract] [Full Text] [Related]
19. Symptomatic cerebral hyperperfusion on SPECT after indirect revascularization surgery for Moyamoya disease.
Cho WS; Lee HY; Kang HS; Kim JE; Bang JS; Oh CW
Clin Nucl Med; 2013 Jan; 38(1):44-6. PubMed ID: 23242046
[TBL] [Abstract][Full Text] [Related]
20. Extensive brain infarction involving deep structures during an acetazolamide-challenged single-photon emission computed tomography scan in a patient with moyamoya disease.
Chong S; Park JD; Chae JH; Cheon JE; Kim SK; Phi JH; Lee JY; Paeng JC; Wang KC
Childs Nerv Syst; 2017 Nov; 33(11):2029-2033. PubMed ID: 28689345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
